tradingkey.logo

NewGenIvf Group Ltd

NIVF
查看详细走势图
0.797USD
-0.020-2.49%
收盘 12/24, 13:00美东报价延迟15分钟
343.36K总市值
0.00市盈率 TTM

NewGenIvf Group Ltd

0.797
-0.020-2.49%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-2.49%

5天

-11.39%

1月

-51.34%

6月

-97.05%

今年开始到现在

-99.96%

1年

-99.95%

查看详细走势图

TradingKey NewGenIvf Group Ltd股票评分

单位: USD 更新时间: 2025-12-24

操作建议

NewGenIvf Group Ltd当前公司基本面数据相对稳定,增长潜力较大。当前估值低估,在医疗服务供应商行业排名74/78位。机构持股占比低,近一月多位分析师给出公司评级为。最高目标价75.00。中期看,股价处于下降通道。近一个月,市场表现非常差,基本面和技术面综合得分也较低。目前股价在压力位和支撑位之间,可以做区间波段操作。

NewGenIvf Group Ltd评分

相关信息

行业排名
74 / 78
全市场排名
521 / 4562
所属行业
医疗服务供应商

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 0 位分析师
--
评级
75.000
目标均价
+5036.99%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

NewGenIvf Group Ltd亮点

亮点风险
NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. It specializes in in-vitro fertilization (IVF) treatment and surrogacy and ancillary caring services. Its fertility treatments, such as IVF, intracytoplasmic sperm injection, intrauterine insemination, egg freezing, embryo transfer, gender selection, semen analysis, hysteroscopy, fertility checkups, testicular sperm aspiration and percutaneous epididymal sperm aspiration. Its clinics are in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. It has acquired cytometry technology and assets including 18 fully constructed cell-sorting and dispensing systems, eight partially constructed units and six patents related to advanced microfluidic systems.
业绩增长期
公司处于发展阶段,最新年度总收入5.43M美元
业绩转亏
公司业绩转亏,最新年度亏损美元
估值合理
公司最新PE估值0.00,处于3年历史合理位
机构加仓
最新机构持股5.79K股,环比增加24.77%

NewGenIvf Group Ltd新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

NewGenIvf Group Ltd简介

NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. It specializes in in-vitro fertilization (IVF) treatment and surrogacy and ancillary caring services. Its fertility treatments, such as IVF, intracytoplasmic sperm injection, intrauterine insemination, egg freezing, embryo transfer, gender selection, semen analysis, hysteroscopy, fertility checkups, testicular sperm aspiration and percutaneous epididymal sperm aspiration. Its clinics are in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. It has acquired cytometry technology and assets including 18 fully constructed cell-sorting and dispensing systems, eight partially constructed units and six patents related to advanced microfluidic systems.
公司代码NIVF
公司NewGenIvf Group Ltd
CEOWing Fung (Siu)
网址https://newgenivf.com/

常见问题

NewGenIvf Group Ltd(NIVF)的当前股价是多少?

NewGenIvf Group Ltd(NIVF)的当前股价是 0.797。

NewGenIvf Group Ltd的股票代码是什么?

NewGenIvf Group Ltd的股票代码是NIVF。

NewGenIvf Group Ltd股票的52周最高点是多少?

NewGenIvf Group Ltd股票的52周最高点是2450.000。

NewGenIvf Group Ltd股票的52周最低点是多少?

NewGenIvf Group Ltd股票的52周最低点是0.781。

NewGenIvf Group Ltd的市值是多少?

NewGenIvf Group Ltd的市值是343.36K。

NewGenIvf Group Ltd的净利润是多少?

NewGenIvf Group Ltd的净利润为-524.64K。

现在NewGenIvf Group Ltd(NIVF)的股票是买入、持有还是卖出?

根据分析师评级,NewGenIvf Group Ltd(NIVF)的总体评级为--,目标价格为75.000。

NewGenIvf Group Ltd(NIVF)股票的每股收益(EPS TTM)是多少

NewGenIvf Group Ltd(NIVF)股票的每股收益(EPS TTM)是576.582。
KeyAI